Limited detection of IgH gene rearrangements in plasma of patients with primary central nervous system lymphoma

[1]  フランク ディール,et al.  Circulating mutant dna to assess tumor dynamics , 2015 .

[2]  J. Villano,et al.  Age, gender, and racial differences in incidence and survival in primary CNS lymphoma , 2011, British Journal of Cancer.

[3]  A. Maitra,et al.  Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development , 2011, Science Translational Medicine.

[4]  L. Deangelis,et al.  YKL‐40 and MMP‐9 as serum markers for patients with primary central nervous system lymphoma , 2011, Annals of neurology.

[5]  K. Kinzler,et al.  IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patients , 2011, Oncotarget.

[6]  P. Angenendt,et al.  Detection of phosphoinositide-3-kinase, catalytic, and alpha polypeptide (PIK3CA) mutations in matched tissue and plasma samples from patients with metastatic breast cancer. , 2010 .

[7]  L. Diaz,et al.  Analysis of circulating tumor DNA to confirm somatic KRAS mutations. , 2009, Journal of the National Cancer Institute.

[8]  L. Swinnen.  Primary central nervous system lymphoma: recent progress, many remaining questions , 2009, Current opinion in oncology.

[9]  K. Kinzler,et al.  Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. , 2007, Cancer research.

[10]  E. Thiel,et al.  Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  U. Schlegel,et al.  Primary central nervous system lymphomas (PCNSL): MRI response criteria revised , 2006, Neurology.

[12]  J. Armitage,et al.  Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[14]  Janet E Olson,et al.  The continuing increase in the incidence of primary central nervous system non‐Hodgkin lymphoma , 2002, Cancer.

[15]  K. Kinzler,et al.  Digital PCR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Uhm.  Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group , 2010 .